Penn Study Points to High Priority Genes as Potential Research Targets in Autistic Spectrum Disorder
The Perelman School of Medicine at the University of Pennsylvania established ASPE, the Autism Spectrum Program of Excellence, in 2017 to significantly improve the understanding of the genetic causes of Autism Spectrum Disorder (ASD) in order to energize the research and clinical community across the globe. The ASPE program was made possible by a generous donation from an anonymous philanthropist.
Genetic studies of ASD will give us greater insight into the genetic roots of the entire autism spectrum. A major focus of ASPE will be on the NRXN1 gene, which codes for the protein neurexin 1 and has been associated with autism spectrum disorder and other psychiatric and neurodevelopmental disorders.
Penn Study Points to High Priority Genes as Potential Research Targets in Autistic Spectrum Disorder
A study of a new mouse model identifies a drug target that has the potential...
Fragile X syndrome (FXS) is the most common genetically inherited cause of intellectual disability in...
Penn will host an international symposium for ASPE in the fall of 2018 to review early findings and stimulate new research avenues. World-renowned developmental psychologist Simon Baron-Cohen, director of the Autism Research Centre at University of Cambridge, will chair ASPE’s external advisory board and give a plenary lecture at the symposium.
Contact us for info regarding the symposium.